Table 1 Descriptive data of the participants, pulmonary function, blood gas variables and exercise variables, reported as mean (SD)
From: Pre-flight evaluation of adult patients with cystic fibrosis: a cross-sectional study
Age and anthropometry (n = 30) | ||||
Age (yrs) | 34.2 (11.81) | |||
Body mass (kg) | 67.7 (16.35) | |||
Height (cm) | 174.4 (9.31) | |||
BMI (kg/m2) | 21.9 (3.65) | |||
Pulmonary function | ||||
FEV1 (L) | 2.25 (1.12) | |||
FEV1 (% predicted) | 58.6 (24.8) | |||
FVC (L) | 3.60 (1.22) | |||
FVC (% of predicted) | 79.4 (20.9) | |||
FEV1/FVC ratio | 60.5 (12.3) | |||
Sea level | Exercise (n = 14) | HAST | HAST slow(n = 20) walking | |
|---|---|---|---|---|
Blood gas variables | ||||
SpO2 (%) | 94.8 (2.2) | 88.6 (8.2) | 88.6 (4.1) | 87.0 (3.8) |
SaO2 (%) | 95.4 (1.5) | 90.1 (8.4) | 89.1 (2.8) | 86.3 (3.8) |
PaO2 (kPa) | 10.2 (1.2) | 9.8 (2.0) | 7.4 (0.9) | 6.9 (0.9) |
PaCO2 (kPa) | 5.0 (0.4) | – | 5.0 (0.3) | 5.0 (0.3) |
Symptoms (BORG 10 CR) | 0.09 (0.23) | – | 0.5 (0.8) | 0.9 (1.1) |
CPET variables | ||||
VE/VCO2 | 33.0 (4.9) | |||
VO2max (ml·kg−1·min−1) | 36.1 (10.5) | |||
VO2max (% predicted) | 87.5 (23.6) | |||
HRmax (beat·min−1) | 175 (14.1) | |||